Enhancing Antitumor Immunity with Antiangiogenic Therapy: A Clinical Model in Renal Cell Carcinoma?

Gao, Xin; McDermott, David F; Michaelson, M Dror

Gao, Xin; McDermott, David F; Michaelson, M Dror.

Affiliation

Gao X; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA xgao4@partners.org.
McDermott DF; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Michaelson MD; Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA.

Oncologist ; 24(6): 725-727, 2019 06.

Article in En | MEDLINE | ID: mdl-31036769

Subject(s)

Angiogenesis Inhibitors/pharmacology; Antineoplastic Agents, Immunological/pharmacology; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Renal Cell/drug therapy; Immunotherapy/methods; Kidney Neoplasms/drug therapy; Angiogenesis Inhibitors/administration & dosage; Antineoplastic Agents, Immunological/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/pharmacology; Carcinoma, Renal Cell/blood supply; Carcinoma, Renal Cell/immunology; Clinical Trials, Phase III as Topic; Drug Synergism; Humans; Kidney Neoplasms/blood supply; Kidney Neoplasms/immunology; Models, Biological; Neovascularization, Pathologic/drug therapy; Neovascularization, Pathologic/immunology; Neovascularization, Pathologic/prevention & control; Prognosis; Randomized Controlled Trials as Topic

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Antineoplastic Combined Chemotherapy Protocols / Angiogenesis Inhibitors / Antineoplastic Agents, Immunological / Immunotherapy / Kidney Neoplasms Type of study: Clinical_trials / Prognostic_studies Limits: Humans Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2019 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google